Research ArticleOpen AccessGoogle Scholar indexed
Prevalence of Metabolic Syndrome in HIV-Infected Cameroonian Patients
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Centre for Food and Nutrition Research (CRAN), Institute of Medical Research and Medicinal Plants Study (IMPM), Ministry of Scientific Research and Innovation, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Centre for Food and Nutrition Research (CRAN), Institute of Medical Research and Medicinal Plants Study (IMPM), Ministry of Scientific Research and Innovation, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Higher Teacher’s Training College (ENS), University of Maroua, Maroua, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Department of Biochemistry and Molecular Biology, University of Buea, Buea, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;INRS-Institut Armand Frappier, Laval, Québec, Canada
Central Hospital, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 1 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Centre for Food and Nutrition Research (CRAN), Institute of Medical Research and Medicinal Plants Study (IMPM), Ministry of Scientific Research and Innovation, Yaounde, Cameroon
- 2 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Centre for Food and Nutrition Research (CRAN), Institute of Medical Research and Medicinal Plants Study (IMPM), Ministry of Scientific Research and Innovation, Yaounde, Cameroon
- 3 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 4 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 5 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 6 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 7 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 8 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Higher Teacher’s Training College (ENS), University of Maroua, Maroua, Cameroon
- 9 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;Department of Biochemistry and Molecular Biology, University of Buea, Buea, Cameroon
- 10 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 11 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon;INRS-Institut Armand Frappier, Laval, Québec, Canada
- 12 Central Hospital, Yaounde, Cameroon
- 13 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
- 14 Department of Biochemistry, Yaounde I University, Yaounde, Cameroon
World Journal of AIDS·Volume 04 (2014)·Pages 85–92·Published 26 February 2014·DOI10.4236/wja.2014.41011
Copy link · social · email
Abstract
Aims: Metabolic complications related to antiretroviral therapy are rarely investigated among HIV-infected patients in Cameroon. The study reports the prevalence of metabolic syndrome and its individual components among HIV-infected Cameroonians. Materials and Methods: We conducted a prospective, cross-sectional study of the prevalence of metabolic syndrome among 492 patients (338 women, 117 men; age range 20 years) recruited at a reference centre, the day hospital, Central Hospital in Yaounde between September 2009 and September 2010. Metabolic syndrome was defined according to IDF (International Diabetes Federation) and NCEP ATP III (National Cholesterol Education Program Adult Treatment Panel III) criteria relative to obesity, glycemic, lipid, arterial blood pressure parameters. Results: The prevalence of metabolic syndrome was 32.8% according to IDF and 30.7% by NCEP (p = 0.0001). The prevalences of individual components according to IDF and NCEP were as follows: abdominal obesity (40.5%; 26.9% respectively), hypertriglyceridemia (55.5%), low HDL cholesterol (42.5%), systolic hypertension (38.2%) diastolic hypertension (28.5%), hyperglycemia (31.2%; 1.3% p = 0.0001). The prevalence of metabolic syndrome was 36% in patients under HAART, 23.4% in naive, (p = 0.0001). Conclusion: The prevalence of metabolic syndrome depends on the presence and the type of HAART used, the definition and the gender.
KeywordsHIVAntiretroviral DrugsAbdominal ObesityDyslipidemiaHypertensionHyperglycemiaMetabolic SyndromePrevalence
- Sterne, J.A., Hernan, M.A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P., et al. (2005) Long-Term Effectiveness of Potent Antiretroviral Therapy in Preventing AIDS and Death: A Prospective Cohort Study. Lancet, 366, 378-384. http://dx.doi.org/10.1016/S0140-6736(05)67022-5
- Hadigan, C., Meigs, J.B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., et al. (2001) Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy. Clinical Infectious Diseases, 32, 130-139. http://dx.doi.org/10.1086/317541
- Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D.J. and Cooper, D.A. (1998) A Syndrome of Peripheral Lipodystrophy, Hyperlipidaemia and Insulin Resistance in Patients Receiving HIV Protease Inhibitors. AIDS, 12, 51-58. http://dx.doi.org/10.1097/00002030-199807000-00003
- Grundy, S.M., Brewer, H.B., Cleeman, J.I., Smith, S.C. and Lenfant, C. (2004) The American Heart Association, the National Heart, Lung and Blood Institute: Definition of Metabolic Syndrome: Report of the National Heart Association Conference on Scientific Issues Related to Definition. Circulation, 109, 433-438. http://dx.doi.org/10.1161/01.CIR.0000111245.75752.C6
- Lakka, H.M., Laaksonen, D., Laaka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J., et al. (2002) The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men. JAMA, 288, 2709-2716. http://dx.doi.org/10.1001/jama.288.21.2709
- Reaven, G.M. (2006) The Metabolic Syndrome: Is This Diagnosis Necessary? The American Journal of Clinical Nutrition, 83, 1237-1247.
- Saves, M., Chêne, G., Ducimetiere, P., Leport, C., Le Moal, G. and Amouyel, P. (2003) Risk Factor for Coronary Heart Diseases in Patients Treated for HIV-Infection Compared with the General Population. Clinical Infectious Diseases, 37, 292-298. http://dx.doi.org/10.1086/375844
- Mondy, K., Overton, E., Grubb, J., Tong, S., Seyfried, W., Powerderly, W. and Yarasheski, K. (2007) Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US OUTPATIENT Population. Clinical Infectious Diseases, 44, 726-734. http://dx.doi.org/10.1086/511679
- Jerico, C., Knobel, H., Montero, M., Knobel, H., Ordonez-Llanos, J., Guelar, A, et al. (2005) Metabolic Syndrome among HIV-Infected Patients: Prevalence, Characteristics, and Related Factors. Diabetes Care, 28, 144-149. http://dx.doi.org/10.2337/diacare.28.1.132
- Sales, S., Campa, A., Makhema, J., Dusara, P., Tsalaile, L., Burns, P.J., et al. (2009) Metabolic Syndrome in HIV + Asymptomatic Adults in Botswana, Africa. The Journal of the Federation of American Societies for Experimental Biology, 918, 4.